Top MIRIO Alternatives

Tempus AI, a leading health tech company located in Chicago, Illinois, is focused on revolutionizing patient care through the integration of advanced artificial intelligence and precision medicine. By harnessing data and AI, the firm aims to develop customized treatment strategies spanning various medical fields, including oncology, cardiology, radiology, and mental health. Their comprehensive platform merges genomic sequencing, clinical data, and AI-driven analytics, thereby providing healthcare professionals and researchers with vital insights. Tempus enhances patient understanding through a variety of testing methodologies, such as tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline testing, as well as tumor-normal matched profiling and minimal residual disease monitoring. In addition, the company presents a fast and reliable platform for test ordering, acquiring patient insights, and integrating AI technologies into medical practice. Their innovative generative AI-enabled clinical assistant further streamlines access to patient insights, improving the efficiency of healthcare delivery. This dedication to leveraging state-of-the-art technology underscores Tempus AI's mission to elevate health outcomes and propel advancements in medical research. Ultimately, Tempus AI strives to be at the forefront of a transformative era in healthcare.

Brainlab's Elements Contrast Clearance Analysis utilizes MRI technology to effectively differentiate between areas of contrast clearance and accumulation in brain tumor imaging datasets. This sophisticated high-resolution technique significantly improves the insight required for ongoing assessments and decision-making in various medical specialties, such as radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The process involves obtaining two standard 3D T1-weighted MRIs; the first is captured approximately five minutes after the injection of a standard contrast agent, followed by a second scan taken between 60 to 105 minutes later. By performing a subtraction of the first series from the latter, volumetric maps are generated that distinctly highlight regions of contrast clearance (depicted in blue) and those of contrast accumulation (marked in red). This information empowers healthcare professionals to more accurately gauge the impacts of radiation therapy against the possibility of tumor regrowth, thus facilitating more informed decisions regarding both initial and ongoing treatment strategies. Consequently, this analytical approach not only supports clinical evaluations but also plays a crucial role in enhancing the overall management of patient care in challenging medical scenarios, ultimately leading to improved patient outcomes.

Mosaiq acts as a comprehensive oncology information system and electronic medical record platform that manages all facets of cancer care, from initial diagnosis and treatment planning to execution, monitoring, and reporting on outcomes. This platform unifies clinical, operational, and financial data into a single, integrated database, allowing healthcare providers access to complete patient records and fostering collaboration among various specialties such as radiation oncology and medical oncology. Additionally, it streamlines vital workflows including chemotherapy order management, planning and administering radiation therapy, scheduling appointments, billing, and clinical documentation. Users are also provided with decision support tools and customizable workflows, which help optimize routine tasks and improve accuracy in care. By incorporating these features, Mosaiq not only enhances the overall efficiency of cancer care delivery but also ensures that healthcare professionals can provide more coordinated and effective treatment plans for their patients. Ultimately, this leads to improved outcomes and a more patient-centered approach in oncology.

Apollo Medical Imaging Technology is an innovative software firm dedicated to improving medical imaging through cutting-edge image processing solutions designed for both clinical settings and research applications. Their flagship product, MIStar, is distinguished by its affordability and user-friendly interface, incorporating a vast array of advanced features and adaptable cross-modality solutions that meet the requirements of both clinicians and original equipment manufacturers. MIStar effectively supports multiple imaging modalities such as CT, MR, NM, and PET, and includes specialized components like CT Perfusion for analyzing strokes and tumors, DSC-MRI for stroke evaluations, and DCE-MRI for tumor diagnostics, along with DWI & ADC and DTI Fiber Tractography for comprehensive assessments. Furthermore, it features NM Renogram Analysis and Image Fusion functionalities, enhancing its utility as a holistic medical imaging tool. The software also guarantees efficient data handling and image input through DICOM networking, paired with a user-friendly clinical database that simplifies the anonymization and archiving of sensitive patient information. This comprehensive suite of capabilities establishes MIStar as an indispensable resource in contemporary medical imaging practices, making it a go-to solution for healthcare professionals striving for excellence in patient care and research.

DoseMeRx is recognized as the world’s first and largest Bayesian dosing platform, specifically designed for clinical applications. Our advanced platform expedites your path to achieving clinical goals while significantly improving patient outcomes and minimizing costs. Distinctively, we are the only Bayesian dosing solution in the world that possesses HITRUST certification, ensuring that patient data is safeguarded with the highest standards of protection and integrity. Benefit from uninterrupted continuity of care across your healthcare system through a few straightforward steps. You can effortlessly standardize your workflows and optimize your therapeutic drug monitoring strategies. Our extensive range of drug models covers various therapeutic areas, including vancomycin and infectious diseases, transplant medicine, cardiovascular and coagulation care, as well as oncology and pediatrics, providing comprehensive support for numerous clinical situations. This adaptability not only enhances the quality of care but also enables healthcare professionals to offer personalized treatment options with greater efficiency. Ultimately, DoseMeRx empowers providers to meet the unique needs of their patients, fostering improved health outcomes across diverse populations.

Merlin's CardioMotionTM echo analysis and reporting software, distributed by CDN in Australia, transforms the approach to quickly diagnosing cardiac issues. It is specifically tailored for use in various medical environments such as emergency departments, CCUs, ICUs, oncology suites, medical center practitioners, ultrasound labs, cardiology sections, and even in rural or isolated areas where point-of-care devices are essential. Additionally, it offers significant benefits for cardiac monitoring in clinical trials. What distinguishes Merlin CardioMotionTM is its unique capability to accurately process slow frame rate echo clips without requiring an ECG trace for detection, thus making it usable with lower-end ultrasound machines. Utilizing advanced image processing technology, the software is grounded in proprietary algorithms that enable the automatic detection of the ventricular wall and its borders. This cutting-edge methodology facilitates a rapid and accurate quantitative assessment of the heart's dynamic performance, leading to improved patient care and outcomes. Consequently, healthcare providers are empowered to make better-informed decisions regarding cardiac health management, ultimately promoting a higher standard of patient well-being.

Brainlab's Elements Spine Stereotactic Radiosurgery (SRS) is an advanced software platform designed to optimize the treatment of spinal metastases. The workflow is characterized by its automation in every stage, which includes detailed anatomical mapping, adjustments for spinal curvature, and precise target identification, ensuring exceptional accuracy and consistency at submillimeter precision. A unique algorithm effectively addresses differences in spinal curvature, enhancing the reliability of image fusion. The system utilizes a patented synthetic tissue model for automatic segmentation, allowing for the accurate identification and labeling of various spinal levels essential for dose calculations. Additionally, tools for defining Gross Tumor Volume (GTV) contours are provided, along with automated recommendations for Clinical Target Volume (CTV) and a cropped spinal canal object that complies with International Spine Consortium Guidelines. The incorporation of AI-driven contouring features facilitates the rapid and accurate delineation of more than 200 anatomical structures, including lymph nodes. This technological development not only simplifies the treatment workflow but also significantly improves patient outcomes in the management of spinal cancer, reflecting a major leap forward in oncological care. As a result, healthcare professionals can deliver more tailored and effective treatment strategies for patients grappling with this challenging condition.

The ARIA® oncology information system is tailored to support both medical and radiation oncology, including proton therapy, ensuring a broad spectrum of functionalities. It facilitates the review and management of clinical images, prescriptions, lab results, quality assurance data, and patient outcomes, among other important information. Cancer staging is automatically aligned with AJCC guidelines, and the system offers flexible management options for toxicities. With a strong focus on interoperability, ARIA enables seamless use of patient data across a variety of devices and platforms. It provides robust support for HL7 and DICOM standards, which simplifies the transfer of patient information between different healthcare facilities. By granting immediate access to patient data, the system empowers healthcare teams to improve their planning capabilities and make real-time adjustments. Additionally, ARIA enhances the effectiveness of image-guided treatment techniques by efficiently utilizing radiographic, fluoroscopic, and cone-beam CT images. The system also keeps track of essential activities for evidence-based Pay-for-Performance programs, all while maintaining compliance with HIPAA regulations. Moreover, ARIA systematically organizes and stores patient data and images, ensuring that healthcare teams remain well-informed and focused on delivering optimal care. This all-encompassing approach not only streamlines workflows but also plays a significant role in improving patient outcomes, ultimately leading to a more effective oncology care experience.

AppliedVR is pioneering the realm of therapeutic virtual reality, utilizing cutting-edge technology to transform the healthcare industry. Founded in 2015, the organization has rolled out scientifically validated digital health solutions that have benefited over 20,000 patients in more than 250 hospitals across eight different countries. Their sophisticated digital wellness platform tackles a range of issues, including both chronic and acute pain, as well as anxiety stemming from surgical procedures, childbirth, oncology treatments, emergency interventions, and rehabilitation processes. The core of appliedVR's approach is deeply anchored in more than thirty years of extensive academic research, shaped by leading authorities in the scientific VR field and esteemed medical professionals. With a variety of medical and consumer-focused products in the pipeline, appliedVR aims to develop the foremost digital pain management platform, transforming treatment methods for pain management in both clinical environments and home settings. This dedication to pushing the boundaries of innovation not only highlights appliedVR's commitment to enhancing patient outcomes but also positions the company as a key player in the evolution of future healthcare practices. As they continue to advance, their influence is set to redefine how pain and anxiety are managed in various medical contexts.

BrainSightAI stands at the forefront of health technology, leveraging artificial intelligence and machine learning to revolutionize the field of brain mapping via AI-driven connectomics, which facilitates the creation of customized brain maps. The VoxelBox product line utilizes these advanced AI methodologies to generate personalized brain maps, aimed at refining pre-surgical planning and enhancing outcomes for patients grappling with brain tumors and various neurological challenges. Additionally, BrainSightAI collaborates with leading hospitals nationwide to conduct clinical trials focused on a spectrum of brain-related ailments, including Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Our primary mission is to advance brain science while enriching the lives of individuals through innovative tools that enhance our comprehension of the human brain. By working closely with healthcare professionals, we aspire to make a meaningful contribution to neurology and the overall quality of patient care, ultimately setting new standards in medical practice. Through our efforts, we hope to foster a brighter future for those affected by neurological conditions.

Suvoda stands as a prominent player in the arena of clinical trial technology, concentrating on complex, life-saving research in areas such as oncology, central nervous system disorders, and rare diseases. Founded in 2013, the organization offers a robust platform equipped with Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all designed to optimize critical patient engagements. Their cutting-edge software ensures a seamless user experience, facilitating precise randomization, effective drug supply management, and prompt data gathering. Committed to enhancing patient comprehension and reducing the burdens faced by trial sites, Suvoda's solutions are crafted to adapt to the growing intricacies of clinical research. Headquartered near Philadelphia, with additional branches throughout Europe and Asia, Suvoda has proudly aided in the execution of over 1,500 trials across more than 85 countries, demonstrating their extensive global influence and proficiency in the industry. Their unwavering focus on innovation and high standards establishes them as an essential ally in the progress of clinical research, paving the way for future breakthroughs and transformations in the field.

Mahalo Health is a comprehensive digital health platform designed to accelerate the development of patient-centered digital health solutions and clinical trials. It offers an array of prebuilt modules that enable the rapid deployment of customizable white-label applications tailored to specific therapeutic areas. The platform is equipped with advanced data capabilities, which include a predictive health engine for anticipating diseases and diagnoses, a behavior modification engine that promotes healthy patient habits, and a notification system that guarantees prompt communication via push notifications, SMS, or emails. Mahalo Health is dedicated to upholding rigorous security and compliance standards, adhering to regulations like HIPAA, GCP, ISO27001, and GDPR. Its diverse service offerings span various therapeutic domains, such as diabetes management, cognitive health, cardiovascular care, musculoskeletal issues, mental well-being, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Furthermore, Mahalo Health not only enhances patient engagement but also improves health outcomes by equipping healthcare providers with innovative digital tools and solutions that adapt to the evolving needs of their patients. This commitment to innovation ensures that healthcare delivery is both efficient and personalized.

Unlock the full potential of your data to elevate the experiences of both your clinic and your patients. InSightive transforms your oncology information into actionable insights that can be implemented without delay. By standardizing and organizing your data through oncology-specific connections, you can achieve improved clarity and accuracy. Utilizing top-tier Tableau visualization, our platform provides analytics customized for the oncology sector, significantly enhancing clinical performance. You can access InSightive through ARIA, a dedicated desktop application, or virtually any web browser, offering flexibility in how you engage with your data. Begin your journey with customizable templates that focus on payer mix, referral sources, and operational efficiency to streamline your processes. Quickly combine activity data to reveal invaluable operational insights, allowing you to explore your information in innovative and relevant ways. Experience fast query results that enable treatment or policy modifications within hours instead of days, empowering your patients to benefit from the collective knowledge of previous cases. Furthermore, our data specialists are on hand to help you effortlessly integrate Varian into your current workflow, ensuring you fully harness the potential of your oncology data for better patient outcomes. With InSightive, you have the future of oncology data management right at your fingertips, ready to drive significant improvements in patient care. Embrace this opportunity to transform your clinic's operations and enhance the overall patient experience.

Omda Cytodose is an oncology medication management system developed by Omda, which utilizes clinically validated protocols along with individualized patient parameters to provide safer and more effective treatment for those facing cancer. This groundbreaking solution improves the quality of care for oncology patients by promoting a cohesive and collaborative treatment environment among healthcare providers, including physicians, pharmacists, and nurses. Designed to accommodate a wide spectrum of adult and pediatric cancers, Omda Cytodose supports various treatment modalities such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Originating from a group of clinicians at one of Norway’s leading cancer facilities, the system was launched in 2001 and has since been widely implemented across healthcare sectors in the Nordic countries, facilitating millions of medication orders. With a robust history spanning 15 years characterized by safety, reliability, and stability, Omda Cytodose is carefully tailored with chemotherapy protocols that align with both national and international standards. This ensures that patients are provided with the most current treatment options available, significantly improving their prospects for successful recovery. As a result, the system not only streamlines medication management but also reinforces the importance of interdisciplinary collaboration in cancer care.

Aissel Technologies is a B2B SaaS company operating at the intersection of artificial intelligence and life sciences strategy. The company develops intelligent software tools that help life sciences teams make better decisions about who to engage, when, and why. Aissel's flagship product, konectar, is used by teams across pharma, biotechnology firms, medtech, and other life science companies to identify and manage relationships with Key Opinion Leaders (KOLs) and Healthcare Professionals (HCPs) globally. The platform analyses data from clinical trials, peer-reviewed publications, HCP payment databases, conference records, and social media activity to generate a dynamic and precise view of the medical landscape. The konectar product suite includes: • konectar — Core KOL identification, profiling, and engagement platform • konectar Events — Tracking upcoming Medical conferences, Pre/post-congress intelligence • konectar Social — Digital opinion leader tracking and social listening • konectar CRM — HCP engagement management and compliance tracking Aissel serves clients ranging from emerging biotech companies to global pharmaceutical enterprises, with coverage across 20+ therapeutic areas and 150,000+ global medical events tracked annually.

ConcertAI emerges as a leading provider of AI-powered solutions in the healthcare industry, with a significant emphasis on oncology. The company's primary goal is to improve patient outcomes and accelerate insights by utilizing high-quality real-world data, innovative AI technologies, and profound scientific expertise. They offer a comprehensive range of products and services designed to enhance both clinical research and the experiences of patients. Their Real-World Data Products provide extensive and tailored datasets that meet a variety of research requirements for different organizations. By streamlining clinical trial processes, their digital trial solution boosts efficiency, while the Clinical Trial Optimization (CTO) platform harnesses advanced AI capabilities to enhance the design and execution of trials, particularly in oncology and hematology. Furthermore, in collaboration with NeoGenomics, ConcertAI has launched CTO-H, a software-as-a-service (SaaS) offering that focuses on hematological malignancies, delivering advanced research analytics and improving operational workflows. This combination of innovative technologies not only bolsters research capabilities but also plays a crucial role in advancing patient care within challenging medical specialties. Ultimately, ConcertAI's commitment to integrating AI into healthcare is reshaping the landscape of oncology and enhancing overall treatment pathways.

Charm Evolution acts as a sophisticated oncology information management platform that streamlines all activities linked to chemotherapy prescribing and administration, enhancing safety, uniformity, and accountability by replacing handwritten orders with carefully tracked digital prescriptions that allow for order modifications and orphan management for accurate waste reporting. It aggregates reliable and secure patient records alongside treatment information from diverse sources into a singular database, thereby promoting informed and effective decision-making at the point of care. In addition, a smart pathway engine automates treatment protocols, optimizes scheduling in line with regimens, and serves both adult and pediatric oncology and hematology through adaptable treatment libraries, protocol validation, and clinical trial management. The platform also features integrated pharmacy management that provides two-way connectivity with compounding facilities, while allowing for the customization of worksheets and labels. Moreover, the scheduling component improves resource utilization and reduces the necessity for patient travel, ultimately enhancing the efficiency of healthcare delivery. By fostering a collaborative framework, this comprehensive system empowers healthcare providers to offer the highest quality of care to their patients while simultaneously streamlining operational workflows.

At Clinipace, we offer a distinctive level of teamwork and oversight that significantly surpasses the standards found in traditional contract research organizations. Our goal is to adeptly navigate you through the intricate processes of your clinical development initiatives. As a comprehensive global CRO, we emphasize a tailored approach to clinical research. We focus on adaptability and cooperation, bolstered by our extensive regulatory knowledge and expertise across a variety of therapeutic fields. Our aim is to revolutionize the clinical research landscape in areas such as oncology, rare diseases, gastroenterology, nephrology, and women's health. By harnessing state-of-the-art technology and a flexible approach, Clinipace is committed to influencing the future of drug development and improving health care results. Our dedication to pioneering solutions allows us to stay ahead in industry advancements, ultimately benefiting the patients we serve. In this rapidly evolving environment, we strive to maintain our leadership position while fostering innovation at every step.

InformAI focuses on developing artificial intelligence solutions aimed at improving medical diagnostics right at the point-of-care, while also increasing the productivity of radiologists. Our innovative AI-powered image classification tools and predictive analytics concerning patient outcomes are crafted in partnership with the Texas Medical Center, the largest medical center complex in the world. By collaborating with leading healthcare organizations, prestigious physician associations, and top-tier medical imaging companies, InformAI is actively transforming the landscape of healthcare delivery. Our team comprises specialists in healthcare, medicine, and artificial intelligence, united in their mission to create advancements that yield improved patient outcomes. Among our standout offerings is the InformAI Sinus Image Classifier, which employs a 3D convolutional neural network (CNN) and is trained on an extensive collection of 6 million radiology-validated 3D CT-scan images, underscoring our dedication to utilizing state-of-the-art technology in medicine. This strategy not only elevates diagnostic precision but also facilitates quicker and more effective patient care, ultimately enhancing the overall healthcare experience. Through these efforts, we aim to set new standards in medical diagnostics and patient treatment.

Inspirata is an AI-powered oncology platform designed to help healthcare organizations optimize their cancer service lines end to end. It enables accurate, complete, and timely cancer reporting to meet state and federal compliance requirements. The platform uses advanced AI and NLP to automate casefinding, tumor classification, and data abstraction in real time. Inspirata unlocks idle clinical data by structuring pathology, radiology, and clinical reports for research and discovery. Built-in workflows improve operational efficiency, reduce staff burden, and enhance care coordination. Real-time trial matching helps increase clinical trial accrual and ensures unbiased access for eligible patients. Patient navigation capabilities support seamless care from diagnosis through treatment and survivorship. Inspirata integrates with EHRs, registries, and research systems using industry standards. Its solutions are continuously updated to reflect best practices and evolving oncology reporting requirements. Used by academic medical centers and cancer programs worldwide, Inspirata improves both clinical outcomes and financial performance. The platform is supported by decades of oncology-focused expertise. Overall, Inspirata helps cancer centers strengthen their reputation, improve quality of care, and accelerate innovation.

IntelliSpace Portal 9.0 represents a groundbreaking visualization platform that incorporates more than 70 clinical applications, offering a unified solution that enhances both speed and efficiency while increasing diagnostic confidence, especially in the evaluation and management of intricate cases. With the aging global population, there is a rising incidence of neurodegenerative conditions that require ongoing monitoring for patients suffering from neurological disorders, which often present subtle alterations in brain structure that are challenging to detect. To tackle these complexities, IntelliSpace Portal 9.0 has unveiled a range of new and upgraded neuro applications, such as NeuroQuant®¹, LoBi, and CT Brain Perfusion, all crafted for rapid, objective, and uniform image evaluation. Furthermore, as awareness of pulmonary health grows, this platform provides a robust set of tools designed to effectively oversee pulmonary diseases from the first signs of detection to continuous follow-up, thereby striving to enhance patient outcomes. The inclusion of both neuro and pulmonary functionalities underscores the significance of IntelliSpace Portal 9.0 as an indispensable asset in the realm of contemporary medical imaging and diagnostics. Its innovative features not only streamline clinical workflows but also empower healthcare professionals to deliver more precise and timely interventions for their patients.

PICOM365 is a comprehensive cloud-based solution for medical imaging, PACS (Picture Archiving and Communication System), and enterprise imaging, which empowers healthcare providers to effectively store, manage, view, report, and share diagnostic images along with relevant clinical data across diverse specialties and locations, ensuring secure and scalable access from any location at any time. Tailored for cloud implementation with hybrid options, this platform adeptly integrates both DICOM and non-DICOM imaging workflows, thereby removing data silos and enabling clinicians to easily retrieve extensive patient imaging records, historical reports, and structured information using a web interface that does not require any downloads. Catering to a variety of imaging fields such as radiology, cardiology, vascular health, women's health, and ophthalmology, PICOM365 seamlessly connects with EHRs, AI applications, analytics, and other external systems, which enhances diagnostic precision and fosters clinical teamwork. Through its forward-thinking design, PICOM365 is transforming the interactions that healthcare professionals have with medical imaging, thereby contributing to better patient outcomes and more efficient workflows throughout the healthcare landscape. By prioritizing user experience and integration capabilities, the platform is becoming an essential tool for modern healthcare organizations aiming for excellence in patient care.

Digimed-MD is recognized as a groundbreaking software solution that enhances the accuracy of medical analyses and diagnoses, promotes a proactive healthcare approach, improves vital sign monitoring, and effectively consolidates a patient’s medical background. Specifically designed for healthcare providers, Digimed-MD equips them with vital tools that support better patient follow-up and ongoing monitoring of essential health metrics. In addition, the software includes a comprehensive demographic profile for every patient, detailing information such as their primary care physician and pharmacist. It further features an extensive clinical profile that tracks allergies, current medications, past surgeries, and existing health conditions, along with a thorough social and medical background. Beyond this, the system incorporates a Therapeutic Nursing Plan, which is an electronic form allowing for the manual entry of clinical data like blood pressure measurements, lipid profiles, healthy weight evaluations, and Framingham risk assessments, in addition to a specialized electronic form for entering clinical notes during patient consultations. By integrating these elements, Digimed-MD not only streamlines patient care but also enhances the overall efficiency and organization of healthcare services, ultimately leading to better health outcomes for patients. This holistic approach ensures that healthcare professionals have all the necessary information readily accessible, fostering more informed decision-making during patient interactions.

Fujifilm's Synapse 3D is an innovative visualization platform developed in collaboration with various medical experts, such as radiologists, cardiologists, and surgeons, featuring over 50 applications aimed at enhancing both diagnostic precision and efficiency. This system incorporates advanced server-side technology that supports both cloud-based and on-premise hosting, facilitating intricate image analyses that assist in interpretation, reporting, and treatment planning while fostering effective clinical collaboration across the organization. It caters to numerous specialty areas, including cardiology, pulmonology, oncology, urology, neurology, and gastroenterology, highlighting its adaptable nature. The scalable architecture of Synapse 3D allows for limitless expansion, and its dependable workflows enhance overall productivity, addressing extensive visualization needs through tailored applications. Additionally, the platform includes specialized cardiology functionalities that improve cardiac care, while its AI-driven detection features markedly boost the accuracy and efficiency of medical interpretations. Furthermore, Synapse 3D seamlessly integrates with Fujifilm's Synapse Enterprise PACS, making it an essential tool for healthcare providers aiming to enhance patient outcomes. With its extensive suite of capabilities, it promises to transform the landscape of medical imaging within clinical environments, ultimately leading to improved care quality and patient satisfaction.

Flatiron Health's Evidence Solutions offer a flexible approach to producing real-world evidence, whether in a prospective or retrospective manner, assisting life sciences companies in effectively achieving their oncology research goals. Central to this suite of services is Flatiron Horizon, an integrated platform that harnesses a vast collection of over 5 million anonymized patient records alongside 1.5 billion data points, enhanced by sophisticated curation strategies and specialized machine learning models tailored for specific diseases. This groundbreaking platform is crafted to support multiple stages of the biopharma lifecycle, from initial discovery and clinical study design to regulatory submissions and post-marketing obligations. Moreover, Flatiron's offerings provide personalized real-world data configurations that are specifically designed for oncology, allowing for prospective evidence generation via minimally invasive studies while refining protocols to improve patient identification. The platform also guarantees a smooth transition of data from electronic health records to electronic data capture systems through the capabilities of Flatiron Clinical Pipe, which enhances both research efficiency and effectiveness. Consequently, such advanced functionalities not only elevate Flatiron Health's standing as a frontrunner in the oncology research landscape but also significantly contribute to the utilization of real-world data in improving patient outcomes. By continuously innovating, Flatiron Health remains committed to advancing the field of oncology through data-driven insights.

Sofpromed focuses on delivering electronic data capture (EDC) solutions specifically designed for firms in the biotechnology, pharmaceutical, and medical device industries that conduct clinical trials across all phases, from I to IV. The EDC system functions as a software platform that streamlines the processes of data collection, validation, and exportation during clinical research. Used worldwide, Sofpromed's EDC software supports a wide array of therapeutic areas, including oncology, hematology, cardiovascular health, metabolic disorders, central nervous system challenges, dermatology, infectious diseases, respiratory issues, and pain management, among others. Its intuitive and user-friendly design allows for swift data entry and straightforward navigation, enhancing user experience. The platform is equipped with essential features like access control and data encryption, ensuring the security of sensitive information. As a fully web-based system, it eliminates installation requirements, promoting both convenience and efficiency. Additional benefits include daily data backups and consistent service reliability, making it a dependable option for users. The system's compatibility across numerous devices, browsers, and operating systems further enhances its usability. It also encompasses integrated monitoring, data management, and reporting tools that maintain compliance with HIPAA, GCP, and 21 CFR regulations. Furthermore, Sofpromed provides a straightforward monthly flat-rate billing structure, which adds to its practicality for various clinical trial requirements. Overall, the combination of its extensive features and focus on user experience establishes it as an indispensable asset for the effective and compliant execution of clinical studies. By adopting such a versatile tool, organizations can improve the quality and efficiency of their data management processes.

PACScribe is a comprehensive cloud-based PACS imaging software developed to support clinicians, radiologists, and healthcare organizations in managing medical imaging workflows. The platform enables secure storage, viewing, and sharing of DICOM images through a web-based system that can be accessed from desktops, tablets, or mobile devices. PACScribe supports a wide range of imaging modalities including MRI, CT scans, X-rays, ultrasound imaging, and specialized diagnostic studies across multiple medical disciplines. Its built-in DICOM viewer allows clinicians to review scans in real time and collaborate with colleagues through secure image sharing. The system also provides advanced annotation tools that allow doctors to mark regions of interest, document observations, and track patient progress over time. PACScribe includes AI-powered analytics that generate structured imaging reports to help clinicians quickly interpret findings and support faster diagnostic decisions. These automated reports reduce manual reporting tasks and highlight key insights for more efficient clinical analysis. The platform integrates with electronic health record systems such as Epic using HL7 and FHIR standards, enabling seamless synchronization between imaging data and patient health records. PACScribe also provides scalable cloud storage that can be deployed on major cloud platforms including AWS, Microsoft Azure, and Google Cloud. Security is a major focus, with encrypted data storage and compliance with healthcare regulations such as HIPAA and GDPR. The platform also supports secure cross-organization sharing, enabling specialists and external consultants to review imaging data remotely. By combining cloud infrastructure, AI-driven analysis, and healthcare system integration, PACScribe helps medical professionals improve diagnostic workflows and deliver faster, data-driven patient care.

Enhance the quality of your patient interactions by reducing the time spent on electronic health records through the efficient workflows provided by OncoEMR®. This innovative platform is specifically designed for oncology practices, equipped with unique tools like Document Search that can significantly reduce task completion time from several minutes to just seconds. As MIPS evolves, OncoEMR® offers vital resources to help navigate the program effectively, facilitating the collection and reporting of necessary data while supporting workflows and compliance with reporting requirements. Tailored for community oncology settings, OncoEMR® includes features such as NCCN Chemotherapy Order Templates® and up-to-date AJCC disease factors, making it an indispensable resource for diagnostics and treatment planning. Before you start using OncoEMR®, Flatiron will ensure that your current EHR database is migrated smoothly, guaranteeing that you can hit the ground running on your first day. Once the migration is complete, you'll have access to more than 150 preloaded reports, allowing you to gather critical insights into your clinical metrics and operational performance, including patient wait times. This comprehensive set of tools not only boosts operational efficiency but also significantly enhances patient care and outcomes within your oncology practice, ultimately leading to a more effective healthcare environment. With OncoEMR®, the focus remains firmly on the patient, ensuring that care remains a top priority.

Fluency for Imaging is an AI-powered radiology reporting platform developed by Jacobian to support faster, more accurate diagnostic reporting in medical imaging workflows. Radiology departments face increasing workloads and complex reporting requirements, which often lead to documentation inefficiencies and cognitive overload for clinicians. Fluency for Imaging addresses these challenges by combining advanced speech recognition technology, AI-driven automation, and structured reporting capabilities into a unified reporting environment. Radiologists can dictate reports using natural speech while the platform automatically organizes the narrative into structured clinical documentation. The system integrates directly with PACS platforms to transfer measurement data, imaging findings, and AI-generated insights directly into the report, eliminating manual transcription and reducing the potential for errors. Fluency for Imaging also incorporates large language model–based ambient reporting features that can listen to dictations, understand clinical context, and generate structured impressions automatically. Built-in guideline support and intelligent nudging help ensure reports follow established medical standards such as BI-RADS, PI-RADS, and TNM classifications. The platform also enables ontology-based coding using clinical standards including RadLex, SNOMED CT, and ICD-10, transforming unstructured text into structured, data-rich reports suitable for analytics, research, and clinical decision support. Multimedia reporting features allow radiologists to include annotated images, tables, and visual diagrams to improve report clarity for referring physicians. Additionally, Fluency for Imaging supports interoperability through standards such as HL7, FHIR, and FHIRcast, enabling seamless communication between imaging systems, hospital information systems, and analytics platforms.

InsiteOne operates as an all-encompassing platform for enterprise imaging, unifying medical imaging, data management, and diagnostic workflows into one cloud-capable solution. It includes a vendor-neutral archive that stores imaging and clinical data across multiple departments such as radiology, cardiology, and pathology, while complying with standards like DICOM, FHIR, and IHE to ensure seamless interoperability among different systems. This versatile platform supports a variety of deployment models, whether on-premises, in the public or private cloud, or as a hybrid solution, thus enabling centralized data storage, automated lifecycle management, enriched metadata, and robust encrypted protection of data, alongside geographically diverse disaster recovery options that help secure a vast amount of clinical images and patient records. Beyond storage, InsiteOne boosts accessibility to enterprise imaging by offering clinicians the ability to view diagnostic images via a zero-footprint, browser-based viewer that works on desktops, tablets, and mobile devices, allowing for measurements, 3D volume rendering, and in-depth reviews without requiring specialized workstations. This multifaceted strategy not only streamlines the imaging process but also greatly enhances the efficiency of clinical workflows, ultimately leading to improved patient care and outcomes. Additionally, the platform's emphasis on interoperability ensures that different healthcare systems can collaborate more effectively, thereby contributing to a more cohesive healthcare environment.